Primary therapy for prostate cancer does not reduce the frequency of end-of-life urologic procedures, according to the findings of a population-based study.
Minimizing incontinence after radical prostatectomy: Lessons learned
"I've worked in 3 different countries, I've seen dozens of people doing robotic radical prostatectomy...so my current practice is kind of a “best of” what I have seen and learned," says Ricardo Soares, MD.
Dr. Kishan highlights findings from the MIRAGE trial in prostate cancer
Amar Kishan, MD, highlights findings showing that MRI-guided SBRT is superior to CT-guided SBRT in localized prostate cancer.
Study shows potential for TKI treatment breaks in patients with renal cell carcinoma
The median overall survival in renal cell carcinoma patients was similar, regardless of whether or not patients received a break from treatment.
Speaking of Urology: ASCO GU 2023 Highlights
Laura Bukavina, MD, and Kyle Rose, MD, discuss some of the notable abstracts from the 2023 ASCO GU conference.
CBD oil does not reduce pain in patients after ureteroscopy
"While CBD oil appears safe, it does not seem to reduce pain or discomfort during the typically brief recovery period after this common procedure,” says Karen Stern, MD.
Urologist Ash Tewari appointed Surgeon-in-Chief of Tisch Cancer Hospital
Ash Tewari, MBBS, MCh, is Chair of the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai.
2 Clarke Drive Cranbury, NJ 08512